Annual Shareholders Equity
$15.82 B
+$3.81 B+31.67%
31 December 2023
Summary:
Novo Nordisk A/S annual stockholders equity is currently $15.82 billion, with the most recent change of +$3.81 billion (+31.67%) on 31 December 2023. During the last 3 years, it has risen by +$5.35 billion (+51.16%). NVO annual shareholders equity is now at all-time high.NVO Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$18.05 B
+$1.90 B+11.76%
30 September 2024
Summary:
Novo Nordisk A/S quarterly stockholders equity is currently $18.05 billion, with the most recent change of +$1.90 billion (+11.76%) on 30 September 2024. Over the past year, it has increased by +$4.88 billion (+37.07%). NVO quarterly shareholders equity is now at all-time high.NVO Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NVO Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +31.7% | +37.1% |
| 3 y3 years | +51.2% | +75.0% |
| 5 y5 years | +99.2% | +132.6% |
NVO Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +51.2% | at high | +80.8% |
| 5 y | 5 years | at high | +99.2% | at high | +132.6% |
| alltime | all time | at high | +3913.3% | at high | +4479.1% |
Novo Nordisk A/S Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $18.05 B(+11.8%) |
| June 2024 | - | $16.15 B(+12.9%) |
| Mar 2024 | - | $14.31 B(-9.6%) |
| Dec 2023 | $15.82 B(+31.7%) | $15.82 B(+20.1%) |
| Sept 2023 | - | $13.17 B(-0.2%) |
| June 2023 | - | $13.20 B(+12.9%) |
| Mar 2023 | - | $11.69 B(-2.7%) |
| Dec 2022 | $12.02 B(+11.6%) | $12.02 B(+18.6%) |
| Sept 2022 | - | $10.13 B(-3.0%) |
| June 2022 | - | $10.45 B(+4.7%) |
| Mar 2022 | - | $9.99 B(-7.3%) |
| Dec 2021 | $10.77 B(+2.9%) | $10.77 B(+4.4%) |
| Sept 2021 | - | $10.31 B(-1.7%) |
| June 2021 | - | $10.49 B(+13.8%) |
| Mar 2021 | - | $9.22 B(-11.9%) |
| Dec 2020 | $10.47 B(+21.2%) | $10.47 B(+11.4%) |
| Sept 2020 | - | $9.39 B(+3.7%) |
| June 2020 | - | $9.06 B(+12.8%) |
| Mar 2020 | - | $8.03 B(-7.0%) |
| Dec 2019 | $8.63 B(+8.7%) | $8.63 B(+11.3%) |
| Sept 2019 | - | $7.76 B(-4.0%) |
| June 2019 | - | $8.09 B(+13.7%) |
| Mar 2019 | - | $7.11 B(-10.5%) |
| Dec 2018 | $7.94 B(-1.1%) | $7.94 B(+7.4%) |
| Sept 2018 | - | $7.39 B(-2.9%) |
| June 2018 | - | $7.61 B(+4.1%) |
| Mar 2018 | - | $7.31 B(-8.9%) |
| Dec 2017 | $8.03 B(+24.7%) | $8.03 B(+8.0%) |
| Sept 2017 | - | $7.43 B(-0.3%) |
| June 2017 | - | $7.45 B(+28.7%) |
| Mar 2017 | - | $5.79 B(-10.1%) |
| Dec 2016 | $6.44 B(-6.4%) | $6.44 B(+3.5%) |
| Sept 2016 | - | $6.22 B(-2.3%) |
| June 2016 | - | $6.37 B(+12.3%) |
| Mar 2016 | - | $5.67 B(-17.6%) |
| Dec 2015 | $6.88 B(+4.6%) | $6.88 B(+5.8%) |
| Sept 2015 | - | $6.50 B(+10.6%) |
| June 2015 | - | $5.88 B(+26.3%) |
| Mar 2015 | - | $4.65 B(-29.2%) |
| Dec 2014 | $6.58 B(-16.5%) | $6.58 B(+1.7%) |
| Sept 2014 | - | $6.47 B(-3.5%) |
| June 2014 | - | $6.71 B(+8.5%) |
| Mar 2014 | - | $6.18 B(-21.5%) |
| Dec 2013 | $7.88 B(+9.4%) | $7.88 B(+11.3%) |
| Sept 2013 | - | $7.08 B(+14.6%) |
| June 2013 | - | $6.18 B(+6.3%) |
| Mar 2013 | - | $5.81 B(-19.3%) |
| Dec 2012 | $7.20 B(+10.4%) | $7.20 B(+16.6%) |
| Sept 2012 | - | $6.17 B(+17.7%) |
| June 2012 | - | $5.24 B(-9.4%) |
| Mar 2012 | - | $5.79 B(-11.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | $6.53 B(-1.0%) | $6.53 B(+0.9%) |
| Sept 2011 | - | $6.47 B(-9.9%) |
| June 2011 | - | $7.17 B(+9.0%) |
| Mar 2011 | - | $6.58 B(-0.2%) |
| Dec 2010 | $6.59 B(-4.1%) | $6.59 B(+5.3%) |
| Sept 2010 | - | $6.26 B(+13.4%) |
| June 2010 | - | $5.52 B(-7.5%) |
| Mar 2010 | - | $5.97 B(-13.1%) |
| Dec 2009 | $6.87 B(+10.8%) | $6.87 B(+0.2%) |
| Sept 2009 | - | $6.86 B(+6.8%) |
| June 2009 | - | $6.42 B(+15.3%) |
| Mar 2009 | - | $5.57 B(-10.2%) |
| Dec 2008 | $6.20 B(-1.6%) | $6.20 B(+2.2%) |
| Sept 2008 | - | $6.07 B(-13.0%) |
| June 2008 | - | $6.98 B(+5.8%) |
| Mar 2008 | - | $6.59 B(+4.7%) |
| Dec 2007 | $6.30 B(+18.3%) | $6.30 B(-0.7%) |
| Sept 2007 | - | $6.34 B(+4.2%) |
| June 2007 | - | $6.09 B(+14.5%) |
| Mar 2007 | - | $5.32 B(-0.2%) |
| Dec 2006 | $5.33 B(+21.7%) | $5.33 B(+10.7%) |
| Sept 2006 | - | $4.81 B(-2.8%) |
| June 2006 | - | $4.95 B(+12.8%) |
| Mar 2006 | - | $4.39 B(+0.3%) |
| Dec 2005 | $4.38 B(-9.9%) | $4.38 B(+2.3%) |
| Sept 2005 | - | $4.28 B(+3.1%) |
| June 2005 | - | $4.15 B(-7.4%) |
| Mar 2005 | - | $4.48 B(-7.8%) |
| Dec 2004 | $4.86 B(+13.6%) | $4.86 B(+13.4%) |
| Sept 2004 | - | $4.28 B(+4.8%) |
| June 2004 | - | $4.09 B(+3.4%) |
| Mar 2004 | - | $3.95 B(-7.7%) |
| Dec 2003 | $4.28 B(+32.4%) | $4.28 B(+32.4%) |
| Dec 2002 | $3.23 B(+35.8%) | $3.23 B(+35.8%) |
| Dec 2001 | $2.38 B(+21.2%) | $2.38 B(+21.2%) |
| Dec 2000 | $1.96 B(-4.3%) | $1.96 B(-4.3%) |
| Dec 1999 | $2.05 B(-27.1%) | $2.05 B(-27.1%) |
| Dec 1998 | $2.82 B(+5.9%) | $2.82 B(+5.9%) |
| Dec 1997 | $2.66 B(-1.4%) | $2.66 B(-1.4%) |
| Dec 1996 | $2.69 B(+3.8%) | $2.69 B(+3.8%) |
| Dec 1995 | $2.60 B(+20.2%) | $2.60 B(+20.2%) |
| Dec 1994 | $2.16 B(+22.3%) | $2.16 B(+22.3%) |
| Dec 1993 | $1.77 B(+4.6%) | $1.77 B(+4.6%) |
| Dec 1992 | $1.69 B(+5.0%) | $1.69 B(+5.0%) |
| Dec 1991 | $1.61 B(+32.2%) | $1.61 B(+32.2%) |
| Dec 1990 | $1.22 B(+28.5%) | $1.22 B(+28.5%) |
| Dec 1989 | $946.19 M(+17.8%) | $946.19 M(+17.8%) |
| Dec 1988 | $803.00 M(-5.1%) | $803.00 M(-5.1%) |
| Dec 1987 | $846.44 M(+52.7%) | $846.44 M(+52.7%) |
| Dec 1986 | $554.32 M(+1.1%) | $554.32 M(+1.1%) |
| Dec 1985 | $548.05 M(+39.0%) | $548.05 M(+39.0%) |
| Dec 1984 | $394.23 M | $394.23 M |
FAQ
- What is Novo Nordisk A/S annual stockholders equity?
- What is the all time high annual shareholders equity for Novo Nordisk A/S?
- What is Novo Nordisk A/S annual shareholders equity year-on-year change?
- What is Novo Nordisk A/S quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Novo Nordisk A/S?
- What is Novo Nordisk A/S quarterly shareholders equity year-on-year change?
What is Novo Nordisk A/S annual stockholders equity?
The current annual shareholders equity of NVO is $15.82 B
What is the all time high annual shareholders equity for Novo Nordisk A/S?
Novo Nordisk A/S all-time high annual stockholders equity is $15.82 B
What is Novo Nordisk A/S annual shareholders equity year-on-year change?
Over the past year, NVO annual stockholders equity has changed by +$3.81 B (+31.67%)
What is Novo Nordisk A/S quarterly stockholders equity?
The current quarterly shareholders equity of NVO is $18.05 B
What is the all time high quarterly shareholders equity for Novo Nordisk A/S?
Novo Nordisk A/S all-time high quarterly stockholders equity is $18.05 B
What is Novo Nordisk A/S quarterly shareholders equity year-on-year change?
Over the past year, NVO quarterly stockholders equity has changed by +$4.88 B (+37.07%)